Immunomodulatory effects of IL-23 and IL-17 in a mouse model of allergic rhinitis

Clinical and Experimental Allergy

Volumn 43, Issue 8, 2013, Pages 956-966

  Wang, M ^a,b   Zhang, W ^a,b   Shang, J ^a   Yang, J ^a   Zhang, L ^a,b   Bachert, C ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Allergic rhinitis; Immunomodulation; Interleukin 17; Interleukin 23; Mouse model of AR

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 23; INTERLEUKIN 23 ANTIBODY; OVALBUMIN;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CERVICAL LYMPH NODE; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG RECHALLENGE; EOSINOPHIL; IMMUNOMODULATION; IN VITRO STUDY; MALE; MAST CELL; MOUSE; NEUTROPHIL; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SNEEZING; TH2 CELL;

ALLERGIC RHINITIS; IMMUNOMODULATION; INTERLEUKIN-17; INTERLEUKIN-23; MOUSE MODEL OF AR;

ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKIN-23 SUBUNIT P19; MALE; MAST CELLS; MICE; NEUTROPHIL INFILTRATION; NEUTROPHILS; OVALBUMIN; RHINITIS, ALLERGIC, PERENNIAL; TH2 CELLS;

EID: 84880973846     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12123     Document Type: Article

References (34)

1. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123-32.
2. Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201:233-40.
3. McGeachy MJ, Bak-Jensen KS, Chen Y et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007; 8:1390-7.
4. Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 2009; 129:1339-50.
5. Cornelissen F, van Hamburg JP, Lubberts E. The IL-12/IL-23 axis and its role in Th17 cell development, pathology and plasticity in arthritis. Curr Opin Investig Drugs 2009; 10:452-62.
6. Sarra M, Pallone F, Macdonald TT, Monteleone G. IL-23/IL-17 axis in IBD. Inflamm Bowel Dis 2010; 16:1808-13.
7. Wakashin H, Hirose K, Maezawa Y et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 2008; 178:1023-32.
8. Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD. Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol 2008; 9:873-9.
9. Li Y, Sun M, Cheng H et al. Silencing IL-23 expression by a small hairpin RNA protects against asthma in mice. Exp Mol Med 2011; 43:197-204.
10. Schnyder-Candrian S, Togbe D, Couillin I et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 2006; 203:2715-25.
11. Xu G, Zhang L, Wang DY et al. Opposing roles of IL-17A and IL-25 in the regulation of TSLP production in human nasal epithelial cells. Allergy 2010; 65:581-9.
12. Semik-Orzech A, Barczyk A, Wiaderkiewicz R, Pierzchala W. Interleukin 17 and RANTES levels in induced sputum of patients with allergic rhinitis after a single nasal allergen challenge. Ann Allergy Asthma Immunol 2009; 103:418-24.
13. Ciprandi G, Fenoglio D, De Amici M, Quaglini S, Negrini S, Filaci G. Serum IL-17 levels in patients with allergic rhinitis. J Allergy Clin Immunol 2008; 122:650-1, e2.
14. Ciprandi G, De Amici M, Murdaca G et al. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy 2009; 64:1375-8.
15. Ciprandi G, Filaci G, Battaglia F, Fenoglio D. Peripheral Th-17 cells in allergic rhinitis: new evidence. Int Immuno pharmacol 2010; 10:226-9.
16. Quan SH, Zhang YL, Han DH, Iwakura Y, Rhee CS. Contribution of interleukin 17A to the development and regulation of allergic inflammation in a murine allergic rhinitis model. Ann Allergy Asthma Immunol 2012; 108:342-50.
17. Wolvers DA, Coenen-de Roo CJ, Mebius REet al. Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39. J Immunol 1999; 162:1994-8.
18. Liu Y, Lu X, Yu HJ et al. The expression of osteopontin and its association with Clara cell 10 kDa protein in allergic rhinitis. Clin Exp Allergy 2010; 40:1632-41.
19. Xie JJ, Wang J, Tang TT et al. The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Cytokine 2010; 49:185-93.
20. Zelante T, De Luca A, Bonifazi P et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007; 37:2695-706.
21. Won HY, Min HJ, Ahn JH et al. Anti-allergic function and regulatory mechanisms of KR62980 in allergen-induced airway inflammation. Biochem Pharmacol 2010; 79:888-96.
22. Phipps S, Lam CE, Mahalingam S et al. Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood 2007; 110:1578-86.
23. Hellings PW, Kasran A, Liu Z et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 2003; 28:42-50.
24. Laan M, Linden A. IL-17 as a potential target for modulating airway neutrophilia. Curr Pharm Des 2002; 8:1855-61.
25. Takatsu K, Nakajima H. IL-5 and eosinophilia. Curr Opin Immunol 2008; 20:288-94.
26. Peng J, Yang XO, Chang SH, Yang J, Dong C. IL-23 signaling enhances Th2 polarization and regulates allergic airway inflammation. Cell Res 2010; 20:62-71.
27. Minai-Fleminger Y, Elishmereni M, Vita F et al. Ultrastructural evidence for human mast cell-eosinophil interactions in vitro. Cell Tissue Res 2010; 341:405-15.
28. Wong CK, Ng SS, Lun SW, Cao J, Lam CW. Signalling mechanisms regulating the activation of human eosinophils by mast-cell-derived chymase: implications for mast cell-eosinophil interaction in allergic inflammation. Immunology 2009; 126:579-87.
29. Caruso RA, Fedele F, Zuccalà V, Fracassi MG, Venuti A. Mast cell and eosinophil interaction in gastric carcinomas: ultrastructural observations. Anticancer Res 2007; 27:391-4.
30. + Ag-mediated mast cell migration in an autocrine/paracrine fashion. Blood 2005; 105:3222-9.
31. Sly LM, Kalesnikoff J, Lam V et al. IgE-induced mast cell survival requires the prolonged generation of reactive oxygen species. J Immunol 2008; 181:3850-60.
32. Mathias CB, Freyschmidt EJ, Caplan B et al. IgE influences the number and function of mature mast cells, but not progenitor recruitment in allergic pulmonary inflammation. J Immunol 2009; 182:2416-24.
33. Suzukawa M, Morita H, Nambu A et al. Epithelial cell-derived IL-25, but not Th17 cell-derived IL-17 or IL-17F, is crucial for murine asthma. J Immunol 2012; 189:3641-52.
34. Sin B, Togias A. Pathophysiology of allergic and nonallergic rhinitis. Proc Am Thorac Soc 2011; 8:106-14.